Table 1.
Chr | SNP | Position | A1/A2 | Gene name | P-value | Direction |
---|---|---|---|---|---|---|
9 | rs10989904 | 104030215 | T/G | 1.65E-04 | −− | |
14 | rs234601 | 96146269 | T/C | 2.12E-04 | −− | |
17 | rs11656215 | 17393792 | T/C | PEMT | 4.25E-04 | −− |
1 | rs708723 | 204005889 | T/C | RAB29, NUCKS1, SLC41A1, SLC45A3 | 4.52E-04 | ++ |
15 | rs7167122 | 58162157 | T/C | 5.48E-04 | −− | |
19 | rs375323 | 11247225 | T/C | DOCK6 | 6.94E-04 | −− |
17 | rs1901187 | 35899673 | T/C | TNS4 | 8.59E-04 | ++ |
4 | rs4557213 | 177926127 | A/G | VEGF-C | 9.18E-04 | ++ |
17 | rs4073996 | 75056346 | T/C | 9.33E-04 | −− | |
11 | rs2656198 | 98868897 | A/G | 1.11E-03 | −− |
Chr, chromosome; SNP, single nucleotide polymorphism; Position, chromosome positions at hg19, A1, reference allele, A2, alternative allele, GeneName, genes including SNPs, P-value, meta-analysis p-value, Direction, summary of the effect of the direction for each study.